Research > ETFs > ETF / ETP Commentary > 

Is Russia on Your Radar? 'RSX' and 'RSXJ' Are Thriving

2020 was obviously a forgettable year for most countries in terms of gross domestic product (GDP), but countries like Russia are finding out that last year didn’t end as poorly as expected. This adds to the case for single-country Russia ETFs such as the VanEck Vectors Russia ETF (RSX B+) and the VanEck Vectors Russia Small-Cap ETF (RSXJ B-).RSX seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS Russia Index. The index includes securities, which may include depositary receipts, of Russian companies.A company is generally considered to be a Russian company if it is incorporated in Russia or is incorporated outside of Russia but has at least 50% of its revenues/related assets in Russia. Such companies may include medium-capitalization companies.Overall, RSX provides exposure to:The Nation’s First ETF Focused on Russia: Largest, most liquid Russia ETF versus competing U.S.-listed ETFs.A Value Opportunity: Russia’s equity market is currently offering deep discounts versus emerging markets as a whole.A Pure Play: Companies must be incorporated in, or derive at least 50% of total revenues from Russia to be added to the index.RSXJ seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® Russia Small-Cap Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund’s benchmark index.The index includes securities of Russian small-capitalization companies. It will normally invest at least 80% of its total assets in securities of small-capitalization Russian companies.Summarily, RSXJ gives investors a:Small Cap Focus: Small-caps may offer greater exposure to domestic growth, less exposure to global cyclicals.Value Opportunity: Russia’s equity market is currently offering deep discounts when compared to other emerging markets.Pure Play: Fund companies must be incorporated in or derive at least 50% of total revenues from Russia to be added to the index.Russia Was Better Off Than Its Peers in 2020As mentioned, global economies in 2020 suffered from the pandemic, but Russia is finding out that its contraction in GDP wasn’t as gruesome as anticipated. Per a Bloomberg article, “Russia suffered a smaller contraction than most major economies in 2020 after the government opted not to reimpose a lockdown in the second half of the year.”“Gross domestic product contracted 3.1% last year, the biggest slump since 2009, Russia’s Federal Statistics Service said Monday,” the article added further. “The contraction was softer than expected by economists, who forecast a 3.7% drop in a Bloomberg survey. The Economy Ministry had projected a decrease of 3.9%.”While the rollout of a Covid-19 vaccine should help, the pandemic still remains a wild card in the global landscape. That said, economists are warning that the vaccine won’t be an immediate panacea for GDPs around the world.For more news and information, visit the Tactical Allocation Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.